Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (361-370 of 692) with videos related to

Pageof 70
Sort By:
JAMA|June 25, 2009
Migraine headache in middle age and late-life brain infarctsAnn I Scher, Larus S Gudmundsson, Sigurdur Sigurdsson, et al.
Cancer|December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumorsA D Seidman, H I Scher, M H Heinemann, et al.
Neurology|September 19, 2014
Midlife migraine and late-life parkinsonism: AGES-Reykjavik studyAnn I Scher, G Webster Ross, Sigurdur Sigurdsson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1979
Characterization of the immunosuppressive state during Schistosoma mansoni infectionA M Attallah, A H Smith, K D Murrell, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PETE C S C Etchebehere, H A Macapinlac, M Gonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2016
Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate CancerMichael J Morris, Dana E Rathkopf, William Novotny, et al.
Pediatric Research|November 1, 2002
The risk of mortality or cerebral palsy in twins: a collaborative population-based studyAnn I Scher, Bev Petterson, Eve Blair, et al.
Cancer|February 8, 2017
Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxelAndrew J Armstrong, Fred Saad, De Phung, et al.
Urology|July 1, 1997
Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinomaR A Ghossein, J Rosai, H I Scher, et al.
The Journal of Experimental Medicine|November 1, 1983
Establishment of an inbred line of mice that express a synergistic immune defect precluding in vitro responses to type 1 and type 2 antigens, B cell mitogens, and a number of T cell-derived helper factorsJ J Mond, G Norton, W E Paul, et al.
Pageof 70

Showing results (361-370 of 692) with videos related to

Sort By:
Pageof 70
JAMA|June 25, 2009
Migraine headache in middle age and late-life brain infarctsAnn I Scher, Larus S Gudmundsson, Sigurdur Sigurdsson, et al.
Cancer|December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumorsA D Seidman, H I Scher, M H Heinemann, et al.
Neurology|September 19, 2014
Midlife migraine and late-life parkinsonism: AGES-Reykjavik studyAnn I Scher, G Webster Ross, Sigurdur Sigurdsson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1979
Characterization of the immunosuppressive state during Schistosoma mansoni infectionA M Attallah, A H Smith, K D Murrell, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PETE C S C Etchebehere, H A Macapinlac, M Gonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2016
Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate CancerMichael J Morris, Dana E Rathkopf, William Novotny, et al.
Pediatric Research|November 1, 2002
The risk of mortality or cerebral palsy in twins: a collaborative population-based studyAnn I Scher, Bev Petterson, Eve Blair, et al.
Cancer|February 8, 2017
Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxelAndrew J Armstrong, Fred Saad, De Phung, et al.
Urology|July 1, 1997
Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinomaR A Ghossein, J Rosai, H I Scher, et al.
The Journal of Experimental Medicine|November 1, 1983
Establishment of an inbred line of mice that express a synergistic immune defect precluding in vitro responses to type 1 and type 2 antigens, B cell mitogens, and a number of T cell-derived helper factorsJ J Mond, G Norton, W E Paul, et al.
Pageof 70